Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Blankson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cellular Immunology|August 1, 1994
The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigensJ N Blankson, S S Morse
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Structured therapeutic interruptions: a reviewJ N Blankson, R F Siliciano
The Journal of Clinical Investigation|March 10, 2001
MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapyJ N Blankson, R F Siliciano
Immunology|May 1, 1995
Superantigens and conventional antigens induce different responses in alpha beta T-cell receptor transgenic miceJ N Blankson, D Y Loh, S S Morse
The Journal of Infectious Diseases|February 15, 2001
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitutionJ N Blankson, J E Gallant, R F Siliciano
The Journal of Infectious Diseases|November 9, 2000
Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infectionJ N Blankson, D Finzi, T C Pierson, et al.
HIV Medicine|November 16, 2019
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populationsR M Brusca, D B Hanna, N I Wada, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cellular Immunology|August 1, 1994
The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigensJ N Blankson, S S Morse
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Structured therapeutic interruptions: a reviewJ N Blankson, R F Siliciano
The Journal of Clinical Investigation|March 10, 2001
MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapyJ N Blankson, R F Siliciano
Immunology|May 1, 1995
Superantigens and conventional antigens induce different responses in alpha beta T-cell receptor transgenic miceJ N Blankson, D Y Loh, S S Morse
The Journal of Infectious Diseases|February 15, 2001
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitutionJ N Blankson, J E Gallant, R F Siliciano
The Journal of Infectious Diseases|November 9, 2000
Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infectionJ N Blankson, D Finzi, T C Pierson, et al.
HIV Medicine|November 16, 2019
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populationsR M Brusca, D B Hanna, N I Wada, et al.
Pageof 1